During the past decade, Cary J. Kohlenberg MD., SC dba IPC Research conducted 1 clinical trials. In the 10-year time frame, 1 clinical trials started and 1 clinical trials were completed, i.e. on average, 100% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Cary J. Kohlenberg MD., SC dba IPC Research" #1 collaborator was "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Cary J. Kohlenberg MD., SC dba IPC Research" are "Alzheimer's Disease" (1 trials) and "Depressive Disorder, Major" (1 trials). Many other conditions were trialed in "Cary J. Kohlenberg MD., SC dba IPC Research" in a lesser frequency.

Most popular intervention types in "Cary J. Kohlenberg MD., SC dba IPC Research" are "Drug" (2 trials). Other intervention types were less common.

The name of intervention was led by "Matching placebo to Quetiapine XR" (1 trials), "Matching placebo to Seltorexant" (1 trials), "Placebo" (1 trials), "Quetiapine XR" (1 trials) and "Seltorexant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Cary J. Kohlenberg MD., SC dba IPC Research" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Cary J. Kohlenberg MD., SC dba IPC Research". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Cary J. Kohlenberg MD., SC dba IPC Research, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Cary J. Kohlenberg MD., SC dba IPC Research, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".